LOW DOSAGE COMBINATIONS OF FLUOXETINE AND REBOXETINE FOR TREATING OBESITY

摘要

The present invention relates to a pharmaceutical composition for improved treatment of obesity. In particular, the present invention relates to compositions comprising a combination of norepinephrine reuptake inhibitors and selective serotonin reuptake inhibitors, and use thereof for treating obesity including reducing the severity of obesity.